Gilead Is Up 3.5% Today. Regeneron Is Down 40% From Its High.
Daily Trader Insights Same biopharma category. One is quietly building something the market is missing.
T-Mobile vs. AT&T. Both Report July 22. One Is the Better Buy.
Same earnings window, same sector, very different bets.
The Inflation Tollbooth Most Investors Walk Past
Pricing power is the single most durable competitive advantage in any market cycle.
AppLovin Is Up 27% in Two Weeks. The Bigger Move May Still Be Ahead.
Its AI ad engine just went global. E-commerce could be the next frontier.
Microsoft Is Down 25% From Its High. July 29 Changes the Conversation.
Azure just hit 40% growth. The stock is trading at its cheapest forward multiple in three years.
SpaceX Joins the Nasdaq-100 in Two Days. The Forced Buying Is Already Priced In.
What happens to SPCX after the mechanical flow ends is the only question that matters now.
AMD Is Up 27% Since Earnings. August 4 Is What Matters Now.
A $11.2B revenue guide, a July AI event, and a data center business that just crossed a structural line.
Oil Just Fell Back to Pre-War Levels. The Real Trade Is Not Energy Stocks.
Crude is back near $68. The second-order beneficiaries of that collapse are hiding in plain sight.
Europe’s Defense Boom Is Hitting a Wall
The spending is real. The question now is whether the companies can actually deliver.
The Yen Just Hit a 40-Year Low. The Unwind Hasn’t Started.
The BOJ is at 1% and signaling more. The carry trade is bigger than ever.